(redirected from Multidrug resistance)
Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia, Wikipedia.


An effective upper bound on prices achieved because of many willing sellers at that price level.

Resistance Level

In technical analysis, a price that a security does not, or only rarely, rise above. Technical analysts identify a resistance level by looking at past performance. When the security approaches the resistance level, it is seen as an indication to sell the security, which will increase the supply, causing the security's price to fall back below the resistance level. If there are too many buyers, however, the security rises above the resistance level. When this occurs, the price of the security will likely continue to rise until it finds another resistance level. It is also called the overhead resistance level. See also: Price ceiling, Support (Support level).


An increased supply of a security. Compare support.


Resistance, or resistance level, is the top of a stock's current trading range, and the point at which the price is higher than investors are willing to pay. As stockholders sell at resistance level, the stock price goes down because supply exceeds demand.

For example, if, on a repeated basis, as stock A's price reaches $60, stockholders begin to sell, then $60 is considered its resistance level. But a trading range isn't fixed and investor attitudes change, so the resistance level tends to move higher or lower over time.

If stock A rises to $63 without a surge of selling, the current resistance line has been breached. This may be the result of a rising market or a bullish assessment of the stock's value. On the other hand, if selling increases at $57, that may become the new resistance level.

Conversely, the level at which demand exceeds supply and investors typically buy a certain stock is called support. It's the point that's considered the bottom of a stock's current trading range.

Technical analysts use the concepts of resistance and support in anticipating future stock price movements.

References in periodicals archive ?
glabrata (3-3), which is the main species exhibiting multiazole, echinocandin, and multidrug resistance (resistance to at least 2 classes of antifungal drugs) (6-3).
Expression of Bcl-xL can confer a multidrug resistance phenotype.
A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporine-A in an attempt to reverse multidrug resistance.
However, the role of tanshinones in circumvention of multidrug resistance has not been fully studied yet.
Top 10 Countries for Multidrug Resistance Research (ranked by number of senior researchers)
The most significant barriers to achieving these goals exist in Africa, where the HIV epidemic has led to an increased vulnerability to tuberculosis, and in Eastern Europe, where tuberculosis rates doubled during the 1990s, and multidrug resistance is high due to low compliance.
However, the ability of cancer cells to become simultaneously resistant to different drugs, a trait known as multidrug resistance (MDR), limits the efficacy of chemotherapy (Baird and Kaye, 2003).
The functions and structure of ABC transporters: implications for the design of new inhibitors of Pgp and MRP1 to control multidrug resistance (MDR).
Based on patient data collected from Chest Hospital, multidrug resistance occurred in 42.
Molecular Devices Corporation (Nasdaq: MDCC), a leader in innovative solutions for drug discovery and life sciences research, today announced the launch of the FLIPR(R) Multidrug Resistance Assay Kit-its first reagent product targeted at ADME/TOX and the cancer drug discovery market.
We believe that the stable linkers and potent, cytotoxic drugs utilized in our ADC technology may be able to overcome two of the major obstacles to anti-CD33 ADC development: non-targeted toxicity and multidrug resistance (MDR).

Full browser ?